News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
243,401 Results
Type
Article (16098)
Company Profile (23)
Press Release (227280)
Multimedia
Podcasts (23)
Webinars (4)
Section
Business (64345)
Career Advice (641)
Deals (10589)
Drug Delivery (36)
Drug Development (41414)
Employer Resources (36)
FDA (6872)
Job Trends (5546)
News (122957)
Policy (12010)
Tag
2024 BioMidwest Digital (1)
2024 Biotech Bay Standard (2)
2024 Biotech Beach Digital (1)
2024 Biotech Beach Standard (1)
2024 Genetown Standard (3)
2024 Pharm Country Standard (1)
2026 BioMidwest Elite (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (1)
Academia (1496)
Accelerated approval (3)
Adcomms (11)
Allergies (30)
Alliances (14440)
ALS (52)
Alzheimer's disease (935)
Antibody-drug conjugate (ADC) (46)
Approvals (6903)
Artificial intelligence (79)
Autoimmune disease (7)
Automation (9)
Bankruptcy (119)
Best Places to Work (5006)
BIOSECURE Act (2)
Biosimilars (20)
Biotechnology (20)
Bladder cancer (61)
Brain cancer (14)
Breast cancer (124)
Cancer (1095)
Cardiovascular disease (115)
Career advice (527)
Career pathing (13)
CAR-T (64)
Cell therapy (181)
Cervical cancer (9)
Clinical research (33661)
Collaboration (276)
Compensation (170)
Complete response letters (7)
COVID-19 (1009)
CRISPR (21)
C-suite (64)
Cystic fibrosis (52)
Data (1376)
Denatured (1)
Depression (17)
Diabetes (143)
Diagnostics (2364)
Digital health (5)
Diversity (1)
Diversity, equity & inclusion (13)
Drug discovery (54)
Drug pricing (32)
Drug shortages (15)
Duchenne muscular dystrophy (101)
Earnings (29837)
Editorial (11)
Employer branding (3)
Employer resources (33)
Events (36184)
Executive appointments (226)
FDA (7513)
Featured Employer (10)
Friedreich's ataxia (2)
Frontotemporal dementia (4)
Funding (258)
Gene editing (50)
Generative AI (7)
Gene therapy (219)
GLP-1 (362)
Government (1999)
Grass and pollen (1)
Guidances (26)
Healthcare (7920)
Huntington's disease (12)
IgA nephropathy (21)
Immunology and inflammation (39)
Indications (15)
Infectious disease (1075)
Inflammatory bowel disease (53)
Inflation Reduction Act (1)
Influenza (16)
Intellectual property (39)
Interviews (85)
IPO (5653)
IRA (12)
Job creations (767)
Job search strategy (482)
Kidney cancer (6)
Labor market (7)
Layoffs (130)
Leadership (5)
Legal (1999)
Liver cancer (30)
Lung cancer (154)
Lymphoma (87)
Machine learning (3)
Management (12)
Manufacturing (82)
MASH (72)
Medical device (4773)
Medtech (4774)
Mergers & acquisitions (5113)
Metabolic disorders (386)
Multiple sclerosis (42)
NASH (19)
Neurodegenerative disease (51)
Neuropsychiatric disorders (12)
Neuroscience (1222)
NextGen: Class of 2025 (2343)
Non-profit (2001)
Northern California (1248)
Now hiring (30)
Obesity (186)
Opinion (73)
Ovarian cancer (35)
Pain (56)
Pancreatic cancer (37)
Parkinson's disease (73)
Partnered (6)
Patents (85)
Patient recruitment (56)
Peanut (17)
People (17880)
Pharmaceutical (7)
Pharmacy benefit managers (4)
Phase I (9865)
Phase II (15139)
Phase III (11454)
Pipeline (633)
Policy (43)
Postmarket research (1418)
Preclinical (4735)
Press Release (18)
Prostate cancer (49)
Psychedelics (9)
Radiopharmaceuticals (112)
Rare diseases (206)
Real estate (1062)
Recruiting (14)
Regulatory (9011)
Reports (8)
Research institute (1049)
Resumes & cover letters (104)
Rett syndrome (5)
RNA editing (1)
RSV (20)
Schizophrenia (42)
Series A (33)
Series B (23)
Service/supplier (1)
Sickle cell disease (23)
Southern California (1048)
Special edition (2)
Spinal muscular atrophy (166)
Sponsored (8)
Startups (1066)
Stomach cancer (3)
Supply chain (22)
Tariffs (5)
The Weekly (21)
United States (9781)
Vaccines (242)
Venture capitalists (7)
Weight loss (101)
Women's health (8)
Worklife (3)
Date
Today (63)
Last 7 days (459)
Last 30 days (1173)
Last 365 days (14387)
2025 (4592)
2024 (15328)
2023 (17167)
2022 (20651)
2021 (22250)
2020 (20997)
2019 (17640)
2018 (13290)
2017 (12434)
2016 (11449)
2015 (13839)
2014 (9521)
2013 (7262)
2012 (7902)
2011 (8129)
2010 (7253)
Location
Africa (224)
Alabama (13)
Alaska (1)
Arizona (44)
Arkansas (4)
Asia (11718)
Australia (2450)
California (2697)
Canada (804)
China (206)
Colorado (104)
Connecticut (100)
Delaware (56)
Europe (30657)
Florida (341)
Georgia (97)
Idaho (17)
Illinois (205)
India (11)
Indiana (134)
Iowa (3)
Japan (84)
Kansas (59)
Kentucky (6)
Louisiana (6)
Maine (29)
Maryland (334)
Massachusetts (1854)
Michigan (66)
Minnesota (117)
Missouri (30)
Montana (11)
Nebraska (10)
Nevada (25)
New Hampshire (29)
New Jersey (871)
New Mexico (5)
New York (822)
North Carolina (403)
North Dakota (4)
Northern California (1248)
Ohio (85)
Oregon (16)
Pennsylvania (581)
Puerto Rico (6)
Rhode Island (3)
South America (317)
South Carolina (8)
South Dakota (1)
Southern California (1048)
Tennessee (46)
Texas (386)
Utah (78)
Virginia (58)
Washington D.C. (16)
Washington State (272)
West Virginia (1)
Wisconsin (13)
243,401 Results for "muscular dystrophy association".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
PepGen Announces Presentations at the 2025 Muscular Dystrophy Association Clinical & Scientific Conference
March 10, 2025
·
4 min read
Press Releases
Precision BioSciences Presents Preclinical Efficacy and Durability Data on PBGENE-DMD for the Treatment of Duchenne Muscular Dystrophy (DMD) at the 2025 Muscular Dystrophy Association (MDA) Clinical & Scientific Conference
March 19, 2025
·
11 min read
Press Releases
Solid Biosciences to Present at the 2025 Muscular Dystrophy Association (MDA) Clinical & Scientific Conference
March 12, 2025
·
5 min read
Press Releases
CHMP recommends EU approval for Duvyzat to treat Duchenne muscular dystrophy
April 28, 2025
·
8 min read
Press Releases
Avidity Biosciences Announces Upcoming Presentations at the Muscular Dystrophy Association (MDA) Clinical & Scientific Conference
March 13, 2025
·
4 min read
Press Releases
Satellos Announces Upcoming Presentation at the 2025 Muscular Dystrophy Association Clinical & Scientific Conference
February 18, 2025
·
6 min read
Policy
Muscular Dystrophy Association Applauds Expanded US FDA Approval of ELEVIDYS Gene Therapy for Duchenne Muscular Dystrophy Patients Ages 4 and Above
The Muscular Dystrophy Association celebrates the U.S. Food and Drug Administration’s expanded approval of ELEVIDYS.
June 20, 2024
·
5 min read
Press Releases
Roche to share latest scientific advancements from its neuromuscular portfolio at Muscular Dystrophy Association (MDA) 2025 conference
March 17, 2025
·
11 min read
Press Releases
Precision BioSciences Announces Oral Presentation at the 2025 Muscular Dystrophy Association (MDA) Clinical & Scientific Conference
February 24, 2025
·
1 min read
Press Releases
Scholar Rock Presents New Phase 3 SAPPHIRE Data at the 2025 Muscular Dystrophy Association Clinical & Scientific Conference
March 17, 2025
·
13 min read
1 of 24,341
Next
